CheckOrphan
BioEnergy
GreenBio
BioBasel
 
left shadow
bottom shadow
top top
Syngenta receives approval for new corn technology in The Philippines
Tuesday, December 8, 2009

Manila, The Philippines - Syngenta announced today that it received cultivation approval for its corn trait GA21 in the Philippines, following biosafety and other required assessments by the Department of Agriculture.

The GA21 trait genetically enhances corn seeds with a built-in resistance to herbicides, offering growers increased productivity and reduced production costs.

In addition, the cultivation of GA21 corn will enable Syngenta to accelerate the development and introduction of better hybrid varieties and new traits, responding to the growing demand across the Asia Pacific region.

“This approval further strengthens Syngenta?s portfolio of high-quality seeds and allows us to continue bringing advanced agricultural technology to the growers in this region,” said Peter Pickering, Region Head APAC, Syngenta Seeds.

Syngenta is one of the world's leading companies with more than 24,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com or www.growmorefromless.com.

Syngenta Media Enquiries:
Andrew McConville  Singapore  +65 9729 6009

Syngenta Cautionary Statement Regarding Forward-Looking Statements
This document contains forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefore.

Source: Syngenta
   
logo